52 week share price peak peak occurred just after announcement of Swiss Regulatory approval. Shortly after, company announced termination of Daniel Kenny as CEO. Has been all downhill since with share price quickly approaching a 52 week low.
very difficult to see any green fields in the short term and really needs a key announcement to kick start the company such as an FDA approval or new sales in the UK. TGA submission was over a year ago. Additional information was requested by the TGA but i don’t think we were privy to the demands.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.025(2.43%) |
Mkt cap ! $14.29M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.05 | $1.00 | $41.05K | 40.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 1249 | 1 |
View Market Depth
| Last trade - 15.47pm 20/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |